GROW vs IVZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

GROW

60.5
AI Score
VS
IVZ Wins

IVZ

69.5
AI Score

Investment Advisor Scores

GROW

61score
Recommendation
HOLD

IVZ

70score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GROW IVZ Winner
Forward P/E 28.8184 9.5147 IVZ
PEG Ratio 0 0.9008 Tie
Revenue Growth 39.1% 20.5% GROW
Earnings Growth 480.9% 35.0% GROW
Tradestie Score 60.5/100 69.5/100 IVZ
Profit Margin 29.8% -0.9% GROW
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

GROW 1M: -10.2% · 3M: -4.3% IVZ 1M: -3.2% · 3M: +10.3%

Current Technical Phase

GROW

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.8%), weak momentum, RSI 41

RSI (14): 40.5 · Price: $2.90

IVZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.8 · Price: $30.71

Fundamentals Snapshot

Metric GROW IVZ
Market Cap — —
Forward P/E 28.8 9.3
Trailing P/E 12.0 —
Revenue (TTM) — —
Revenue Growth 0.4% 0.2%
Gross Margin 0.5% 0.3%
Operating Margin 0.0% 0.2%
EPS 0.24 -0.68
Dividend Yield 0.03% 0.03%

Frequently Asked Questions

Based on our detailed analysis, IVZ is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.